Track topics on Twitter Track topics that are important to you
Insulin glargine, marketed under the names Lantus among others, is a longacting basal insulin analogue, given once daily to help control the blood sugar level of those with diabetes. It consists of microcrystals that slowly release insulin, giving a long duration of action of 18 to 26 hours, with a "peakless" profile according to the insulin glargine package insert.
The global Insulin Glargine market will reach xxx Million USD in 2017 with CAGR xx% from 20182023. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
Single Dose Vial
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Treat type 1 diabetes
Treat type 2 diabetes
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Middle East Africa
Endocrine disorders are grouped into two categories: hormone imbalance - when a gland produces too much or too little of an endocrine hormone development of lesions (such as nodules or tumors) in the endocrine system, which may or may not affect...
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...